Clinical Trial Study on the Improved New Method of Acupotomy for AS
Clinical Trial Study on the Improved New Method of Acupotomy for Ankylosing Spondylitis
China-Japan Friendship Hospital
60 participants
Dec 2, 2025
INTERVENTIONAL
Conditions
Summary
This study employs a randomized controlled trial methodology to systematically evaluate the efficacy and safety of a modified acupotomy technique in the treatment of ankylosing spondylitis. Through ultrasound-guided localization, the operative sites are assessed to clarify the improvement effect of the modified acupotomy on disease activity in AS patients. The aim is to enhance the clinical outcomes of AS, provide evidence-based medical support for acupotomy treatment of AS, and improve the diagnosis and treatment standards for the condition.
Eligibility
Inclusion Criteria4
- Meeting the 1984 revised New York criteria or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis
- Age 18-75 years
- BASDAI ≥4
- Signed informed consent form
Exclusion Criteria6
- Presence of autoimmune diseases other than the studied condition
- Complete spinal ankylosis or spinal deformity
- Pregnant or lactating women
- Comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, malignant tumors, or coagulation disorders
- Patients unable to comply with data collection due to mental, linguistic, or similar factors
- Patients with psoriatic arthritis, reactive arthritis, or inflammatory bowel disease-associated spondyloarthritis
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
All subjects were enrolled at week 0 and, after completing baseline assessments, received acupotomy treatment once per week for a total of four sessions over the initial three-week period. The core intervention for the treatment group (acupotomy group) involved ultrasound-guided precise release: first, the target vertebra with the most significant lesions was identified through palpation and ultrasound imaging, after which the acupotomy was accurately guided in real-time via ultrasound to the interspinous points (located at the interspinous ligaments) and paraspinal points (located at the intertransverse ligaments) of the target vertebra and adjacent vertebrae for release.
The control group (sham acupotomy group) strictly replicated all preliminary procedures of the treatment group, including exploration, ultrasound localization, and local anesthesia. However, the acupotomy needle only pierced the epidermis without performing any release operations in the deeper tissues, thereby maintaining blinding and assessing the specific effect of the acupotomy therapy.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07578220